Showing 6811-6820 of 10171 results for "".
- Dove Launches DermaSeries Product Line for Dry Skin Plus Companion Campaignhttps://practicaldermatology.com/news/dove-launches-dermaseries-product-line-for-dry-skin-plus-companion-campaign/2457904/Dove is rolling out NEW Dove DermaSeries, a completely hypoallergenic and fragrance-free range of cleansers and lotions formulated especially for the driest skin. A companion campaign --
- Eyelid SCC On the Rise in Englandhttps://practicaldermatology.com/news/eyelid-scc-on-the-rise-in-england/2457911/Cases of a squamous cell carcinoma (SCC) in the eyelids is on the rise in England, according to new research in the British Journal of Ophthalmology. Specifically, there has been an annual increase
- Alastin Skincare Launches Restorative Neck Complexhttps://practicaldermatology.com/news/alastin-skincare-launches-restorative-neck-complex/2457916/Alastin Skincare, Inc. has incorporated its proven, proprietary TriHex Technology into a new product designed for the specific needs of the neck and décolletage: Restorative Neck Complexwith TriHex Technology. This breakthrough treatment is formulated to addr
- Anti-IL22 Therapy May Represent New Treatment Option for Severe ADhttps://practicaldermatology.com/news/researchers-close-in-on-possible-new-treatment-for-severe-ad/2457913/New research suggests that IL-22/Th22 targeting may offer a novel treatment alternative for patients with severe atopic dermatitis (AD). The findings, which appear in the Journal of the American Academy of Dermatology, provide the first e
- Cochrane Review: Biologics Trump Other Systemics for Psohttps://practicaldermatology.com/news/cochrane-review-biologics-trump-other-systemic-meds-for-pso/2457924/Biologics appear to be the most effective systemic medicines for achieving a chronic plaque psoriasis score of PASI (Psoriasis Area and Severity Index) 90, according to a newly published Cochrane Revie
- Smart Beauty Devices Take Center Stage at CES 2018https://practicaldermatology.com/news/smart-beauty-devices-take-center-stage-at-ces-2018/2457927/The Computer Electronics Show is known as the see-and-be scene for techies – and beauty products and devices always take center stage. “Shopping for skincare products can be an overwhelming and confusing experience for our consumer because she is uncertain about what her
- New Ceramide-Infused Skin Barrier Product Reduces Costs for Ostomy Carehttps://practicaldermatology.com/news/new-ceramide-infused-skin-barrier-product-reduces-costs-for-ostomy-care/2457929/Ostomy patients using a new type of skin barrier product infused with ceramides may experience lower costs of care, according to a randomized trial published
- AAD Issues New Guidelines for Treatment of Non-melanoma Skin Cancerhttps://practicaldermatology.com/news/aad-issues-new-guidelines-for-treatment-of-non-melanoma-skin-cancer/2457928/The American Academy of Dermatology (AAD) has addressed the growing health concern about non-melanoma skin cancers (NMSC) with the release of its guidelines of care for the management of basal cell carcinoma and cutaneous squamous cell carcinoma, published online in the Journal of the Am
- Cutera Introduces Juliet and Secret RFhttps://practicaldermatology.com/news/cutera-introduces-juliet-and-secret-rf/2457930/Cutera has introduced two new devices to its laser and energy-based device offerings: Juliet™ and Secret RF
- Jiangsu Hengrui Medicine and Arcutis Partner for Immune-Mediated Dermatology Therapy Using SHR0302https://practicaldermatology.com/news/jiangsu-hengrui-medicine-and-arcutis-partner-for-immune-mediated-dermatology-therapy-using-shr0302/2457936/Jiangsu Hengrui Medicine Co., Ltd., a fully integrated biopharmaceutical company based in Shanghai, and Arcutis, Inc., a biotechnology company based in Menlo Park, CA, entered into an exclusive option and license agreement for the development and commercialization of topical applications of Hengr